Preclinical Scientist
SNIPR Biome | Copenhagen Ø, Denmark | Full-time
Are you passionate about pioneering CRISPR-based medicines to combat global superbugs and treat infectious and metabolic disorders? Are you a hands-on microbiologist who thrives at the bench — running high-throughput phage and antibacterial efficacy assays, working with biofilms and planktonic bacteria, and translating your in vitro findings into well-designed in vivo studies? Do you have experience conducting in vivo infectious disease experiments and a keen interest in applying those skills to advance a next-generation therapy pipeline? Would you like to be part of a diverse, passionate, and fun team at SNIPR? If so, you will have genuine ownership of your work, scientific variety, and the chance to make a measurable difference for patients — as part of a diverse, international team of 40+ in the heart of Copenhagen (www.sniprbiome.com).
ABOUT SNIPR
SNIPR is a clinical-stage biotechnology company pioneering CRISPR-powered precision medicines to combat antimicrobial resistance (AMR). Using proprietary CRISPR technology and delivery platforms, we develop therapies that selectively eliminate pathogenic bacteria while preserving the healthy microbiome.
Our lead programme, SNIPR001 — an oral cocktail of CRISPR-armed phages targeting fluoroquinolone-resistant E. coli in immunocompromised patients — is currently in Phase 2 clinical trials, following a successful Phase 1 study published in The Lancet Microbe (2026). Our pipeline spans five AMR programmes, four of which are in research and preclinical development, supported by partnerships with CARB-X, SPRIN-D, the Gates Foundation, the Cystic Fibrosis Foundation, and the European Investment Bank.
SNIPR is based in the Innovation District of Copenhagen, Denmark. We have raised more than $90 million, hold 30+ granted US patents, and employ a diverse team of 40+ from top academic institutions and biotech companies worldwide.
THE ROLE & KEY RESPONSIBILITIES
As a Preclinical Scientist at SNIPR, you will be a hands-on, lab-present scientist at the heart of our preclinical programmes. You will design and execute complex in vitro microbiology experiments, develop and apply high-throughput assays to assess phage and antibacterial efficacy, and translate these findings into in vivo studies conducted in collaboration with CROs and academic partners.
Your main tasks include: contributing to designing and running high-throughput in vitro efficacy assays across planktonic and biofilm bacterial models in GMO1 and GMO2, generating robust in vitro datasets that inform programme decisions; contributing to the design of in vivo infectious disease studies in collaboration with the Director of Preclinical Testing and CROs, protocol writing, data analysis, report writing, and presentation of results; analysing biological samples from both in vitro and in vivo experiments; and participating in ongoing innovation work, including identification of new experimental models and targets.
You are expected to initiate scientific discussions, provide innovative solutions, and deliver robust scientific data by working closely with other teams in a matrixed, collaborative environment and by managing and collaborating with external partners (e.g., CROs).
It is essential that you can, in a structured way, handle multiple tasks simultaneously and support colleagues while maintaining a quality mindset and a high level of team spirit.
You will report to the Director of Preclinical Testing and be part of a team of six employees.
QUALIFICTIONS
Required:
- PhD in microbiology, pharmacology, molecular biology, infectious diseases, or a related field.
- Minimum 3–5 years of relevant hands-on experience in a preclinical research setting, from industry or academia.
- Strong hands-on experience in microbiology — including work with planktonic bacteria, biofilm models, bacteriophages, and high-throughput in vitro efficacy assays. Experience with bactericidal assays, phage-host interaction experiments, and clinically relevant infection models is highly valued.
- Extensive experience in collaborating with Contract Research Organisations (CROs) and international academic groups.
Nice to have
- Experience with bacteriophage, microbiome, or live biotherapeutic modalities.
You are
- Self-driven and structured, able to run multiple workstreams independently.
- A collaborative team player who supports colleagues and communicates clearly.
- Detail-oriented, adaptable, and quality-focused.
- Genuinely motivated by infectious disease and AMR, and excited to set a personal mark in a novel therapeutic area.
WHAT WE OFFER
- Competitive salary and a comprehensive benefits package including health insurance, pension, bonus, and a warrant programme.
- A collegial environment in Copenhagen's Innovation District, where you will help shape the future of AMR treatment.
HOW TO APPLY
Please submit your application in English, including your CV with a short motivating paragraph, combined in a single document via LinkedIn.
We will review applications on a rolling basis, and online interviews may be offered in the initial stages of the process.
Application deadline: 10 August 2026
For further questions to the position, you can contact the Director of Preclinical Testing, Niloofar Yavari (ny@sniprbiome.com) including the job title in the email subject line.
